Form 8-K - Current report:
SEC Accession No. 0001193125-25-198777
Filing Date
2025-09-09
Accepted
2025-09-09 07:13:31
Documents
12
Period of Report
2025-09-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d116486d8k.htm   iXBRL 8-K 24057
  Complete submission text file 0001193125-25-198777.txt   145084

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA jbio-20250905.xsd EX-101.SCH 2844
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE jbio-20250905_lab.xml EX-101.LAB 19497
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jbio-20250905_pre.xml EX-101.PRE 12151
15 EXTRACTED XBRL INSTANCE DOCUMENT d116486d8k_htm.xml XML 3938
Mailing Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453 (781) 312-3013
Jade Biosciences, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 251301650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)